Talwin (Hospira, Inc.)


Welcome to the PulseAid listing for the Talwin drug offered from Hospira, Inc.. This Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: PENTAZOCINE LACTATE
SUBSTANCE NAME: PENTAZOCINE LACTATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA]
ROUTE: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-11-18
END MARKETING DATE: 0000-00-00


Talwin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTalwin from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE: CIV
ACTIVE STRENGTH: 30(mg/mL)
START MARKETING DATE: 2005-11-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1941_c3e10d6c-92bc-4625-819c-6d7dea442e44
PRODUCT NDC: 0409-1941
APPLICATION NUMBER: NDA016194

Other PENTAZOCINE LACTATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.Talwin